multi source·5h ago·6 sources analyzed
FDA experiences leadership changes as top drug chief departs
The FDA faces significant leadership shifts following the departure of key officials. The acting drug chief claims she was fired amid these changes. (sources: foxnews, washingtonpost, theguardian, cbsnews, bloomberg)
Image: nbcnews
ModernAction Briefing
Dr. Tracy Beth Høeg, the acting drug chief at the FDA, has departed the agency, claiming she was fired. This follows the resignation of the FDA Commissioner, marking a period of instability within the organization.
- Dr. Tracy Beth Høeg claims she was fired from her position as acting drug chief.
- Her departure is the second high-profile exit from the FDA in less than a week.
- The FDA is undergoing a significant leadership shake-up following these departures.
Why it matters
These leadership changes could affect the FDA's operations and regulatory processes.
Action context
No specific legislation identified for action yet.
Top coverage · 6 sources
foxnewsSecond FDA executive departing organization in less than a week as top drug regulator claims she was firedwashingtonpostFDA official key to vaccine schedule overhaul to departtheguardianFDA turmoil deepens as top drug chief departs claiming she was firedcbsnewsControversial FDA official leaving drug center post in latest departure at agency